Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C DUFRESNE

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Molecular Pharmacology|August 1, 1995
Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclaseD M Slipetz, G P O'Neill, L Favreau, et al.
American Journal of Human Genetics|August 1, 1995
Analysis of phenotypic features and FGFR2 mutations in Apert syndromeW J Park, C Theda, N E Maestri, et al.
Journal of Medicinal Chemistry|April 3, 1992
Development of 2,3-dihydro-6-(3-phenoxypropyl)-2-(2-phenylethyl)-5-benzofuranol (L-670,630) as a potent and orally active inhibitor of 5-lipoxygenaseC K Lau, P C Bélanger, C Dufresne, et al.
Canadian Journal of Physiology and Pharmacology|December 1, 1987
L-656,224 (7-chloro-2-[(4-methoxyphenyl)methyl]-3- methyl-5-propyl-4-benzofuranol): a novel, selective, orally active 5-lipoxygenase inhibitorP Belanger, A Maycock, Y Guindon, et al.
Journal of Medicinal Chemistry|June 1, 1989
Synthesis and structure-activity relationships of a novel class of 5-lipoxygenase inhibitors. 2-(Phenylmethyl)-4-hydroxy-3,5-dialkylbenzofurans: the development of L-656,224C K Lau, P C Bélanger, J Scheigetz, et al.
Journal of Natural Products|November 1, 1993
Zaragozic acids D and D2: potent inhibitors of squalene synthase and of Ras farnesyl-protein transferaseC Dufresne, K E Wilson, S B Singh, et al.
Journal of Natural Products|June 1, 1994
L-741,494, a fungal metabolite that is an inhibitor of interleukin-1 beta converting enzymeM J Salvatore, O D Hensens, D L Zink, et al.
The Journal of Antibiotics|May 1, 1991
Restricticin, a novel glycine-containing antifungal agentR E Schwartz, C Dufresne, J E Flor, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
A series of non-quinoline cysLT1 receptor antagonists: SAR study on pyridyl analogs of SingulairD Guay, J Y Gauthier, C Dufresne, et al.
Journal of Medicinal Chemistry|February 4, 1994
Selective protection and relative importance of the carboxylic acid groups of zaragozic acid A for squalene synthase inhibitionT Biftu, J J Acton, G D Berger, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Molecular Pharmacology|August 1, 1995
Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclaseD M Slipetz, G P O'Neill, L Favreau, et al.
American Journal of Human Genetics|August 1, 1995
Analysis of phenotypic features and FGFR2 mutations in Apert syndromeW J Park, C Theda, N E Maestri, et al.
Journal of Medicinal Chemistry|April 3, 1992
Development of 2,3-dihydro-6-(3-phenoxypropyl)-2-(2-phenylethyl)-5-benzofuranol (L-670,630) as a potent and orally active inhibitor of 5-lipoxygenaseC K Lau, P C Bélanger, C Dufresne, et al.
Canadian Journal of Physiology and Pharmacology|December 1, 1987
L-656,224 (7-chloro-2-[(4-methoxyphenyl)methyl]-3- methyl-5-propyl-4-benzofuranol): a novel, selective, orally active 5-lipoxygenase inhibitorP Belanger, A Maycock, Y Guindon, et al.
Journal of Medicinal Chemistry|June 1, 1989
Synthesis and structure-activity relationships of a novel class of 5-lipoxygenase inhibitors. 2-(Phenylmethyl)-4-hydroxy-3,5-dialkylbenzofurans: the development of L-656,224C K Lau, P C Bélanger, J Scheigetz, et al.
Journal of Natural Products|November 1, 1993
Zaragozic acids D and D2: potent inhibitors of squalene synthase and of Ras farnesyl-protein transferaseC Dufresne, K E Wilson, S B Singh, et al.
Journal of Natural Products|June 1, 1994
L-741,494, a fungal metabolite that is an inhibitor of interleukin-1 beta converting enzymeM J Salvatore, O D Hensens, D L Zink, et al.
The Journal of Antibiotics|May 1, 1991
Restricticin, a novel glycine-containing antifungal agentR E Schwartz, C Dufresne, J E Flor, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
A series of non-quinoline cysLT1 receptor antagonists: SAR study on pyridyl analogs of SingulairD Guay, J Y Gauthier, C Dufresne, et al.
Journal of Medicinal Chemistry|February 4, 1994
Selective protection and relative importance of the carboxylic acid groups of zaragozic acid A for squalene synthase inhibitionT Biftu, J J Acton, G D Berger, et al.
Pageof 7